Safety and efficacy of daratumumab in dialysis-dependent renal failure secondary to multiple myeloma

被引：27
|
作者：
Rocchi, Serena [1 ]
Tacchetti, Paola [1 ]
Pantani, Lucia [1 ]
Mancuso, Katia [1 ]
Zannetti, Beatrice [1 ]
Cavo, Michele [1 ]
Zamagni, Elena [1 ]
机构：
[1] Bologna Univ, Sch Med, Seragnoli Inst Hematol, Bologna, Italy
来源：
HAEMATOLOGICA | 2018年 / 103卷 / 06期
关键词：
DEXAMETHASONE; MONOTHERAPY; LENALIDOMIDE; MANAGEMENT; CD38;
D O I：
10.3324/haematol.2018.191122
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E277 / E278
页数：2
相关论文
共 50 条
  • [1] Daratumumab in dialysis-dependent multiple myeloma
    Jeyaraman, Preethi
    Bhasin, Alka
    Dayal, Nitin
    Pathak, Sangeeta
    Naithani, Rahul
    BLOOD RESEARCH, 2020, 55 (01) : 65 - 67
  • [2] Dialysis-dependent renal failure in patients with multiple myeloma: Reversibility factors
    Rekhtina, I. G.
    Mendeleeva, L. P.
    Biryukova, L. S.
    TERAPEVTICHESKII ARKHIV, 2015, 87 (07) : 72 - 76
  • [3] Efficacy, toxicity and mortality of autologous SCT in multiple myeloma patients with dialysis-dependent renal failure
    St Bernard, R.
    Chodirker, L.
    Masih-Khan, E.
    Jiang, H.
    Franke, N.
    Kukreti, V.
    Tiedemann, R.
    Trudel, S.
    Reece, D.
    Chen, C. I.
    BONE MARROW TRANSPLANTATION, 2015, 50 (01) : 95 - 99
  • [4] Efficacy, toxicity and mortality of autologous SCT in multiple myeloma patients with dialysis-dependent renal failure
    R St Bernard
    L Chodirker
    E Masih-Khan
    H Jiang
    N Franke
    V Kukreti
    R Tiedemann
    S Trudel
    D Reece
    C I Chen
    Bone Marrow Transplantation, 2015, 50 : 95 - 99
  • [5] Safety and efficacy of daratumumab in patients with multiple myeloma and severe renal failure
    Kuzume, Ayumi
    Tabata, Rikako
    Terao, Toshiki
    Tsushima, Takafumi
    Miura, Daisuke
    Narita, Kentaro
    Takeuchi, Masami
    Matsue, Kosei
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 (04) : E33 - E36
  • [6] LENALIDOMIDE IN PATIENTS WITH DIALYSIS-DEPENDENT END STAGE RENAL FAILURE (ESRF) AND MULTIPLE MYELOMA
    Di Ciaccio, P.
    Ling, S.
    HAEMATOLOGICA, 2017, 102 : 801 - 801
  • [7] Renal recovery following daratumumab, lenalidomide, and dexamethasone therapy in a patient with newly diagnosed dialysis-dependent multiple myeloma
    Mizuno, Shinichi
    Kitayama, Chigusa
    Mashiko, Shigeto
    Sanada, Satoru
    CEN CASE REPORTS, 2022, 11 (02) : 265 - 268
  • [8] Renal recovery following daratumumab, lenalidomide, and dexamethasone therapy in a patient with newly diagnosed dialysis-dependent multiple myeloma
    Shinichi Mizuno
    Chigusa Kitayama
    Shigeto Mashiko
    Satoru Sanada
    CEN Case Reports, 2022, 11 : 265 - 268
  • [9] Dialysis-dependent renal failure at diagnosis continues to be associated with very poor outcome in multiple myeloma
    Murphy, Philip T.
    Baldeo, Cherisse
    O'Kelly, Patrick
    Sargant, Jeremy
    Thornton, Patrick
    McCloy, Mary
    Conlon, Peter
    Magee, Colm
    Denton, Mark
    Quinn, John
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 165 (06) : 890 - 891
  • [10] Autologous Haematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma Complicated By Dialysis-Dependent Renal Failure
    Firsova, Maiia V.
    Mendeleeva, Larisa P.
    Rekhtina, Irina G.
    Solovev, Maxim V.
    Pokrovskaya, Olga S.
    Gemdzhian, Eduard
    Biryukova, Ludmila S.
    Savchenko, Valery G.
    BLOOD, 2018, 132
12345